Literature DB >> 3710177

Pharmacological therapy for proliferative vitreoretinopathy.

N D Radtke, A D Weinsieder, R J Ballou.   

Abstract

We developed an animal model in the rabbit eye with intravitreally injected heterotransplanted bovine retinal pigment epithelial cells to test a pharmacological agent which would reduce extracellular matrix formation. Results with 20 and 60 micrograms of cis-hydroxyproline showed a 48% decrease in the rate of traction retinal detachments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710177     DOI: 10.1007/bf02143060

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  26 in total

1.  Retention of nonhelical procollagen containing cis-hydroxyproline in rough endoplasmic reticulum.

Authors:  J Uitto; H Hoffman; D J Prockop
Journal:  Science       Date:  1975-12-19       Impact factor: 47.728

2.  Incorporation of cis-hydroxyproline into protocollagen and collagen. Collagen containing cis-hydroxyproline in place of proline and trans-hydroxyproline is not extruded at a normal rate.

Authors:  J Rosenbloom; D J Prockop
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

3.  Experimental tractional retinal detachment in rabbits. Clinical picture and histopathologic features.

Authors:  M T Trese; M Spitznas; R Y Foos; M O Hall
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

4.  Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation).

Authors:  R Machemer; H Laqua
Journal:  Am J Ophthalmol       Date:  1975-07       Impact factor: 5.258

5.  Glial cell proliferation in human retinal detachment with massive periretinal proliferation.

Authors:  D L Van Horn; T M Aaberg; R Machemer; R Fenzl
Journal:  Am J Ophthalmol       Date:  1977-09       Impact factor: 5.258

6.  The role of cellular proliferation in an experimental model of massive periretinal proliferation.

Authors:  D M Fastenberg; K R Diddie; K Dorey; S J Ryan
Journal:  Am J Ophthalmol       Date:  1982-05       Impact factor: 5.258

7.  Surgical removal of vitreous. Its effect on intraocular fibroblast proliferation in the rabbit.

Authors:  H T Hsu; K Dorey; N Sorgente; S J Ryan
Journal:  Arch Ophthalmol       Date:  1984-04

8.  Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production.

Authors:  W M Lewko; L A Liotta; M S Wicha; B K Vonderhaar; W R Kidwell
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

9.  Further characterization of epiretinal membranes in human massive periretinal proliferation.

Authors:  M M Rodrigues; D A Newsome; R Machemer
Journal:  Curr Eye Res       Date:  1981       Impact factor: 2.424

10.  Simulation of massive periretinal proliferation by autotransplantation of retinal pigment epithelial cells in rabbits.

Authors:  N D Radtke; Y Tano; D Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1981-01       Impact factor: 5.258

View more
  4 in total

Review 1.  Proliferative vitreoretinopathy.

Authors:  P K Leaver
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

Review 2.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

3.  Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy.

Authors:  C M Yang; K R Olsen; E Hernandez; S W Cousins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 4.  Proline metabolism and transport in retinal health and disease.

Authors:  Jianhai Du; Siyan Zhu; Rayne R Lim; Jennifer R Chao
Journal:  Amino Acids       Date:  2021-04-19       Impact factor: 3.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.